Antinociceptive effects of tetrahydrocannabinol side chain analogs: Dependence upon route of administration

European Journal of Pharmacology

Volumn 397, Issue 2-3, 2000, Pages 319-326

  Wiley, Jenny L ^a   Patrick, Gray S ^a   Crocker, Peter C ^b   Saha, Bijali ^b   Razdan, Raj K ^b   Martin, Billy R ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ORGANIX INC   (United States)

Author keywords

Antinociception; Cannabinoid; Intrahecal; Intraventricular; Structure activity relationship; Tetrahydrocannabinol

Indexed keywords

CANNABINOID RECEPTOR; TETRAHYDROCANNABINOL;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG STRUCTURE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR MECHANISM; SPINAL CORD; STRUCTURE ACTIVITY RELATION;

ANALGESICS, NON-NARCOTIC; ANIMALS; DRUG ADMINISTRATION ROUTES; INJECTIONS, INTRAVENTRICULAR; INJECTIONS, SPINAL; MALE; MICE; MICE, INBRED ICR; NOCICEPTORS; PAIN; PAIN MEASUREMENT; STRUCTURE-ACTIVITY RELATIONSHIP; TETRAHYDROCANNABINOL;

EID: 0034595585     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00259-4     Document Type: Article

References (27)

1. 8-THC analogs. Pharmacol. Biochem. Behav. 40:1991;509-512.
2. 9-tetrahydrocannabinol. J. Pharmacol. Exp. Ther. 263:1992;1118-1126.
3. Compton D.R., Rice K.C., De Costa B.R., Razdan R.K., Melvin L.S., Johnson M.R., Martin B.R. Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities. J. Pharmacol. Exp. Ther. 265:1993;218-226.
4. Dewey W.L., Harris L.S., Howes J.F., Nuite J.A. The effect of various neurohumoral modulators on the activity of morphine and the narcotic antagonists in the tail-flick and phenylquinone tests. J. Pharmacol. Exp. Ther. 175:1970;435-442.
5. Hohmann A.G., Tsou K., Walker J.M. Cannabinoid modulation of wide dynamic range neurons in the lumbar dorsal horn of the rat by spinally administered WIN55,212-2. Neurosci. Lett. 257:1998;119-122.
6. 8-THC. Tetrahedron. 53:1997;1557-1576.
7. Lichtman A.H., Martin B.R. Spinal and supraspinal components of cannabinoid-induced antinociception. J. Pharmacol. Exp. Ther. 258:1991;517-523.
8. Mackie K., Devane W.A., Hille B. Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells. Mol. Pharmacol. 44:1993;498-503.
9. Martin B.R., Compton D.R., Thomas B.F., Prescott W.R., Little P.J., Razdan R.K., Johnson M.R., Melvin L.S., Mechoulam R., Ward S.J. Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs. Pharmacol. Biochem. Behav. 40:1991;471-478.
10. 9-THC. Pharmacol. Biochem. Behav. 46:1993;295-301.
11. Martin B.R., Jefferson R., Winckler R., Wiley J.L., Huffman J.W., Crocker P.J., Saha B., Razdan R.K. Manipulation of the tetrahydrocannabinol side chain delineates agonists, partial agonists and antagonists. J. Pharmacol. Exp. Ther. 290:1999;1065-1079.
12. Martin W.J., Lai N.K., Patrick S.L., Tsou K., Walker J.M. Antinociceptive actions of cannabinoids following intraventricular administration in rats. Brain Res. 629:1993;300-304.
13. Martin W.J., Coffin P.O., Attias E., Balinsky M., Tsou K., Walker J.M. Anatomical basis for cannabinoid-induced antinociception as revealed by intracerebral microinjections. Brain Res. 822:1999;237-242.
14. Melvin L., Milne G., Johnson M., Subramaniam B., Wilken G., Howlett A. Structure-actiivity relationships for cannabinoid receptor-binding and analgesic activity: studies of bicyclic cannabinoid analogs. Mol. Pharmacol. 44:1993;1008-1015.
15. Pugh G. Jr., Welch S.P., Bass P.P. Modulation of free intracellular calcium and cAMP by morphine and cannabinoids, alone and in combination in mouse brain and spinal cord synaptosomes. Pharmacol. Biochem. Behav. 49:1994;1093-1100.
16. Razdan R.K. Structure-activity relationships in cannabinoids. Pharmacol. Rev. 38:1986;75-149.
17. 9-THCs. Life Sci. 56:1995;2013-2020.
18. Ryan W.J., Banner K.W., Wiley J.L., Martin B.R., Razdan R.K. Potent anandamide analogs: the effect of changing the length and branching of the end pentyl chain. J. Med. Chem. 40:1997;3617-3625.
19. Seltzman H.H., Fleming D.N., Thomas B.F., Gilliam A.F., McCallion D.S., Pertwee R.G., Compton D.R., Martin B.R. Synthesis and pharmacological comparison of dimethylheptyl and pentyl anandamide analogs. J. Med. Chem. 40:1997;3626-3634.
20. Shire D., Carillon C., Kaghad M., Calandra B., Rinaldi-Carmona M., LeFur G., Caput D., Ferrara P. An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing. J. Biol. Chem. 270:1995;3726-3731.
21. 8-tetrahydrocannabinol. J. Med. Chem. 41:1998;4400-4407.
22. 9-tetrahydrocannabinol-induced analgesia. Brain Res. 578:1992;8-12.
23. Smith P.B., Compton D.R., Welch S.P., Razdan R.K., Mechoulam R., Martin B.R. The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice. J. Pharmacol. Exp. Ther. 270:1994;219-227.
24. Welch S.P., Thomas C., Patrick G.S. Modulation of cannabinoid-induced antinociception after intracerebroventricular versus intrathecal administration to mice: possible mechanisms for interaction with morphine. J. Pharmacol. Exp. Ther. 272:1995;310-321.
25. Welch S.P., Huffman J.W., Lowe J. Differential blockade of the antinociceptive effects of centrally administered cannabinoids by SR141716A. J. Pharmacol. Exp. Ther. 286:1998;1301-1308.
26. 8-tetrahydrocannabinol. Neuropharmacology. 35:1996;1793-1804.
27. Wiley J.L., Compton D.R., Dai D., Lainton J.A.H., Phillips M., Huffman J.W., Martin B.R. Structure-activity relationships of indole- and pyrrole-derived cannabinoids. J. Pharmacol. Exp. Ther. 285:1998;995-1004.